Envoy Medical (COCH) Long-Term Investments (2021 - 2023)

Envoy Medical has disclosed Long-Term Investments across 3 years of filings, most recently posting $44.6 million for Q2 2023.

• In Q2 2023, Long-Term Investments fell 89.51% year-over-year to $44.6 million; the TTM figure through Jun 2023 stood at $44.6 million (down 89.51% YoY), while the FY2022 annual figure was $430.0 million, up 1.18% from the prior year.
• Long-Term Investments came in at $44.6 million for Q2 2023 at Envoy Medical, up from $44.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $430.0 million in Q4 2022 to a low of $44.4 million in Q1 2023.
• Average Long-Term Investments over 3 years is $349.2 million, with a median of $425.0 million recorded in 2021.
• Year-over-year, Long-Term Investments grew 1.21% in 2022 and tumbled 89.56% in 2023.
• Over 3 years, Long-Term Investments stood at $425.0 million in 2021, then grew by 1.18% to $430.0 million in 2022, then tumbled by 89.62% to $44.6 million in 2023.
• Per Business Quant data, the three most recent Long-Term Investments figures were $44.6 million in Q2 2023, $44.4 million in Q1 2023, and $430.0 million in Q4 2022.